ELI LILLY & Co — Director's Dealing 2023

Jan 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-12-25

Reporting Person: Dozier Eric (EVP, HR & Diversity)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4100	Direct
Common Stock	90	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2023-03-01	Common Stock (1602.0)		Direct
Restricted Stock Unit	$	2025-03-01	Common Stock (2403.0)		Direct
Restricted Stock Unit	$	2024-11-01	Common Stock (1534.0)		Direct
Restricted Stock Unit	$	2026-11-01	Common Stock (2300.0)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.